Henlius and Organon Announce US FDA Approval of POHERDY® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US
SHANGHAI & JERSEY CITY, N.J.--(BUSINESS WIRE)--Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced that the US Food...

SBI Research Outlines LTCG Tax Headroom as Air Suvidha Rule Mandated for All Arrivals
Sony kicks off 2026 PlayStation Store Black Friday sale early with up to 75% off games
Democrats Sweep US Midterm Elections, Winning Senate and House as Trump Faces Lame-Duck Presidency
Union Cabinet Approves Two-Year Extension for Agniveer Service Tenure
Kerala Lottery DhanaLekshmi DL-76 results declared for November 4 draw 















